Rosenberg Martin 4
4 · CUBIST PHARMACEUTICALS INC · Filed Apr 3, 2012
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Exercise/Conversion
Common Stock
2012-04-02+10,000→ 14,658 total - Sale
Common Stock
2012-04-02$42.76/sh−10,000$427,597→ 4,658 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-04-02−10,000→ 2,500 totalExercise: $21.88From: 2008-06-07Exp: 2017-06-07→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Option vests 100% on one-year anniversary of grant.
- [F2]Sold pursuant to a Rule 10(b)5-1 Plan
- [F3]This transaction was executed in multiple trades at prices ranging from $42.52 to $43.1150. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.